Literature DB >> 25303118

Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Bradley S Barrett1, Kejun Guo1, Michael S Harper2, Sam X Li2, Karl J Heilman1, Nicholas O Davidson3, Mario L Santiago4.   

Abstract

APOBEC1 is a cytidine deaminase involved in cholesterol metabolism that has been linked to retrovirus restriction, analogous to the evolutionarily-related APOBEC3 proteins. In particular, murine APOBEC1 was shown to inhibit Friend retrovirus (FV) in vitro, generating high levels of C-to-T and G-to-A mutations. These observations raised the possibility that FV infection might be altered in APOBEC1-null mice. To examine this question directly, we infected wild-type and APOBEC1-null mice with FV complex and evaluated acute infection levels. Surprisingly, APOBEC1-null mice exhibited similar cellular infection levels and plasma viremia relative to wild-type mice. Moreover, next-generation sequencing analyses revealed that in contrast to APOBEC3, APOBEC1 did not enhance retroviral C-to-T and G-to-A mutational frequencies in genomic DNA. Thus, APOBEC1 neither inhibited nor significantly drove the molecular evolution of FV in vivo. Our findings reinforce that not all retrovirus restriction factors characterized as potent in vitro may be functionally relevant in vivo.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC1; APOBEC3; Deaminase; Friend retrovirus; HIV-1; Hypermutation; Innate immunity; Restriction factor

Mesh:

Substances:

Year:  2014        PMID: 25303118      PMCID: PMC4430097          DOI: 10.1016/j.virol.2014.09.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  76 in total

1.  Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Stefanie Koch; David Pasdeloup; Marc Labetoulle; Barbara Gaertner; Jean-Pierre Vartanian; Andreas Meyerhans; Simon Wain-Hobson
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.

Authors:  Y Yang; M P Sowden; H C Smith
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

3.  In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).

Authors:  Svend K Petersen-Mahrt; Michael S Neuberger
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

4.  Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution.

Authors:  Kimberly Schmitt; Kejun Guo; Malinda Algaier; Autumn Ruiz; Fang Cheng; Jianming Qiu; Silke Wissing; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2011-08-25       Impact factor: 3.616

5.  APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis.

Authors:  Peter Gee; Yoshinori Ando; Hiroko Kitayama; Seiji P Yamamoto; Yuka Kanemura; Hirotaka Ebina; Yasushi Kawaguchi; Yoshio Koyanagi
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

6.  RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.

Authors:  Tomonori Eto; Kazuo Kinoshita; Kiyotsugu Yoshikawa; Masamichi Muramatsu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

7.  Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection.

Authors:  Sam X Li; Bradley S Barrett; Michael S Harper; Karl J Heilman; Kalani Halemano; Amanda K Steele; Kejun Guo; Robert H Silverman; Mario L Santiago
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

8.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

9.  Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.

Authors:  Terumasa Ikeda; Khaled Hussein Abd El Galil; Kenzo Tokunaga; Kazuhiko Maeda; Tetsutaro Sata; Nobuo Sakaguchi; Thierry Heidmann; Atsushi Koito
Journal:  Nucleic Acids Res       Date:  2011-03-12       Impact factor: 16.971

Review 10.  Mouse knockout models for HIV-1 restriction factors.

Authors:  Jan Rehwinkel
Journal:  Cell Mol Life Sci       Date:  2014-05-23       Impact factor: 9.261

View more
  11 in total

Review 1.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

2.  Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.

Authors:  Kejun Guo; Kalani Halemano; Kimberly Schmitt; Miki Katuwal; Yaqiong Wang; Michael S Harper; Karl J Heilman; Takeo Kuwata; Edward B Stephens; Mario L Santiago
Journal:  Immunogenetics       Date:  2015-05-21       Impact factor: 2.846

3.  Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.

Authors:  Caitlin M Miller; Bradley S Barrett; Jianfang Chen; James H Morrison; Caleb Radomile; Mario L Santiago; Eric M Poeschla
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.

Authors:  Kerry J Lavender; Kathrin Gibbert; Karin E Peterson; Erik Van Dis; Sandra Francois; Tyson Woods; Ronald J Messer; Ali Gawanbacht; Janis A Müller; Jan Münch; Katie Phillips; Brent Race; Michael S Harper; Kejun Guo; Eric J Lee; Mirko Trilling; Hartmut Hengel; Jacob Piehler; Jens Verheyen; Cara C Wilson; Mario L Santiago; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

5.  Opossum APOBEC1 is a DNA mutator with retrovirus and retroelement restriction activity.

Authors:  Terumasa Ikeda; Mayuko Shimoda; Diako Ebrahimi; John L VandeBerg; Reuben S Harris; Atsushi Koito; Kazuhiko Maeda
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

6.  Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence.

Authors:  Sonja Windmann; Lucas Otto; Camilla Patrizia Hrycak; Anna Malyshkina; Nadine Bongard; Paul David; Matthias Gunzer; Ulf Dittmer; Wibke Bayer
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

Review 7.  Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.

Authors:  Ulf Dittmer; Kathrin Sutter; George Kassiotis; Gennadiy Zelinskyy; Zoltán Bánki; Heribert Stoiber; Mario L Santiago; Kim J Hasenkrug
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

8.  Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; George Kassiotis; Kim J Hasenkrug; Ulf Dittmer; Kathrin Gibbert; Mario L Santiago
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

9.  Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.

Authors:  Michael S Harper; Kejun Guo; Kathrin Gibbert; Eric J Lee; Stephanie M Dillon; Bradley S Barrett; Martin D McCarter; Kim J Hasenkrug; Ulf Dittmer; Cara C Wilson; Mario L Santiago
Journal:  PLoS Pathog       Date:  2015-11-03       Impact factor: 6.823

10.  Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses.

Authors:  Elisabeth Littwitz-Salomon; Simone Schimmer; Ulf Dittmer
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.